From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery

Bottom Line

This is a news and perspectives article rather than a research study, making it inappropriate for evidence-based clinical decision-making. While such articles may provide useful background information about emerging technologies in drug discovery, they do not constitute evidence that can inform clinical practice. The article lacks empirical data, systematic methodology, statistical analysis, or clinical outcomes. Healthcare professionals should seek peer-reviewed research studies with appropriate study designs when evaluating evidence for clinical applications. The publication date appears to be in the future (2026), raising questions about the document's authenticity. For evidence-based practice, clinicians should prioritise systematic reviews, randomised controlled trials, and other high-quality research designs over news articles when making clinical decisions.